Go Pro

Universal Q1 Earnings Call Highlights

Universal logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Universal reported a weak fiscal Q1 2027: Revenue fell 12% year over year to $524 million, operating income dropped to $2.3 million, and the company posted a $5 million net loss.
  • Tobacco results were hurt by oversupply and delayed customer purchases: Tobacco revenue declined 13% to $437 million, though management expects shipments and demand to improve in the second half of the fiscal year.
  • The ingredients business remained under pressure, posting an operating loss amid consumer-market headwinds and high fixed costs. Universal plans $55 million–$65 million in fiscal 2027 capital expenditures while maintaining focus on liquidity, dividends and operational investment.
  • Interested in Universal? Here are five stocks we like better.

Universal NYSE: UVV reported lower revenue and a net loss in the first quarter of fiscal 2027, as slower customer purchasing in an oversupplied leaf tobacco market and continued pressure in its ingredients business weighed on results.

Consolidated revenue declined 12% year over year to $524 million, while operating income fell to $2.3 million from $33.8 million in the prior-year quarter. The company posted a net loss attributable to Universal of $5 million, compared with net income of $8.5 million a year earlier.

Chairman, President and CEO Preston Wigner said the first-quarter performance reflected conditions the company had anticipated, including a return to more typical seasonal patterns in its leaf tobacco business following what he described as an exceptional first quarter last year.

Tobacco Results Reflect Slower Buying Activity

Universal's tobacco operations generated first-quarter revenue of $437 million, down 13% from the prior-year period. Segment operating income declined to $3.5 million from $35.7 million a year earlier.

Chief Financial Officer Steve Diel said the company’s first fiscal quarter is typically seasonally slow, but the effect was more pronounced this year as customers delayed purchasing decisions amid oversupply in flue-cured and burley tobacco markets. He said Universal views the change as a timing issue and that expected customer demand for the full year remains consistent with its initial sales plan.

Diel also cited lower carryover crop sales, a less favorable product mix and a $4.4 million negative operating-income variance from foreign-currency movements as factors affecting year-over-year comparisons.

Wigner said shipments are expected to be weighted toward the second half of fiscal 2027. He said the company is focused on disciplined purchasing, monitoring green tobacco trends and maintaining appropriate inventory levels while navigating the oversupplied markets.

During the question-and-answer session, Wigner said farmer pricing has declined in most markets as expected amid the surplus. He said the company’s global sourcing operations, customer relationships and regional teams position it to serve customer needs and potentially gain market share.

Universal estimated unsold flue-cured and burley stocks at approximately 180 million kilograms as of June 30, an increase of about 11 million kilograms from March 31. Diel said uncommitted inventory levels had declined since June 30 and that the company expects them to return to its 20% target as the season progresses.

On dark air-cured tobacco, Wigner said wrapper demand remains strong, while non-wrapper tobacco remains generally oversupplied. He said Universal has introduced sales and inventory-management initiatives intended to reduce inventory, convert wrapper and non-wrapper stock to cash, limit purchases of lower-demand non-wrapper tobacco and support margin optimization. Wigner said he would not expect the large inventory write-downs the company recorded last year.

Ingredients Segment Remains Under Pressure

Universal’s ingredients operations reported revenue of $87 million, down 3% from the prior-year quarter. The segment posted an operating loss of $700,000, compared with operating income of $1.7 million a year earlier.

Diel attributed the performance to persistent consumer-market headwinds and high fixed costs associated with growth investments. He said the company remains confident in its improvement plan but expects tangible progress to take time because product development cycles in the ingredients business are relatively long.

Wigner said Universal remains committed to the ingredients platform as a long-term growth engine. The company is pursuing stronger commercial execution, higher facility utilization, greater operational and financial efficiency, and more profitable volume across its product portfolio.

He pointed particularly to the Lancaster, Pennsylvania campus, where the company has expanded capacity and capabilities. Wigner said utilization at the newer portion of the campus remains below the level Universal wants, though he did not provide a percentage figure. He said efforts to improve the segment are expected to continue through the next fiscal year.

Liquidity, Investment and Capital Allocation

As of June 30, Universal’s net debt stood at slightly more than $1 billion, approximately $52 million below the level a year earlier. Diel said the decrease primarily reflected lower working-capital usage resulting from crop-purchase timing and lower green tobacco prices.

The company had approximately $1.1 billion of liquidity availability, including cash and capacity under committed and uncommitted credit lines.

Diel said working capital should decline from recent years because of lower green tobacco purchase prices, although quarterly levels will depend on sales timing, shipments and carryover crop levels. Interest expense is also expected to decline somewhat from last year due to slower purchasing activity and potentially lower working-capital needs.

Universal expects capital expenditures of $55 million to $65 million during fiscal 2027. Diel said spending this year is more focused on tobacco operations across South America, Africa and Asia, including growth projects, facility efficiencies and automation. He said the company’s capital-allocation priorities remain investing in tobacco operations, supporting the dividend, growing the ingredients segment and, lastly, share repurchases.

The company repurchased shares during the quarter primarily to offset dilution from equity compensation, Diel said. Universal also said it has begun receiving tariff refunds and is working with affected customers on how those funds may be managed.

Looking ahead, Wigner said Universal is also assessing how forecasted El Niño conditions could affect crop supply in certain regions. He said customers are considering potential impacts on next season’s crops, which could create demand for additional volumes during the current year.

About Universal (NYSE:UVV)

Universal Corporation NYSE: UVV is a global agribusiness company primarily engaged in the procurement, processing and sale of leaf tobacco. Headquartered in Richmond, Virginia, the company sources cured leaf tobacco from key growing regions in North and South America, Africa and Asia. Universal serves major multinational tobacco manufacturers by providing a full range of services including inventory management, quality control and logistics support to ensure a consistent and reliable supply of tobacco leaf.

In addition to its core leaf tobacco operations, Universal offers integrated supply-chain services that encompass warehousing, distribution and ingredient sourcing for smokeless and novel tobacco products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Universal Right Now?

Before you consider Universal, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal wasn't on the list.

While Universal currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines